dcterms.isReferencedBy |
Suresh, S., Mahendra, J., Multifactorial relationship of obesity and periodontal disease (2014) J Clin Diagn Res, 8, pp. 1-3; Al-husseini, N., Arafat, N., Mohammed, E., Allam, M., Effect of exercise training on adiponectin receptor expression and insulin resistance in mice fed a high fat diet (2010) Am J Biochem Biotechnol, 6, pp. 77-83. , COI: 1:CAS:528:DC%2BC3cXhtlGjsLrK; Odegaard, J.I., Chawla, A., Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis (2013) Science, 339, pp. 172-177. , COI: 1:CAS:528:DC%2BC3sXjvVCmsg%3D%3D, PID: 23307735; Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030 (2010) Diabetes Res Clin Pract, 87, pp. 4-14. , COI: 1:STN:280:DC%2BC3c%2Fot1Witg%3D%3D, PID: 19896746; Horwich, T., Fonarow, G., Glucose, obesity, metabolic syndrome, and diabetes: relevance to incidence of heart failure (2010) J Am Coll Cardiol, 55, pp. 283-293. , COI: 1:CAS:528:DC%2BC3cXisFertr4%3D, PID: 20117431; Rabe, K., Lehrke, M., Parhofer, K.G., Broedl, U.C., Adipokines and insulin resistance (2008) Mol Med, 14, pp. 741-751. , COI: 1:CAS:528:DC%2BD1cXhsVOgu7jN, PID: 19009016; Bays, H.E., Sick fat, metabolic disease and atherosclerosis (2009) Am J Med, 122, pp. 26-37. , COI: 1:CAS:528:DC%2BD1cXhsFChu7vP, PID: 19110085; Bluher, M., Adipose tissue dysfunction in obesity (2009) Exp Clin Endocrinol Diabetes, 117, pp. 241-250. , COI: 1:STN:280:DC%2BD1MvgsVKhsQ%3D%3D, PID: 19358089; Mattu, H.S., Randeva, H.S., Role of adipokines in cardiovascular disease (2013) J Endocrinol, 216, pp. 17-36; Pan, H.Y., Guo, L., Li, Q., Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes (2010) Diabetes Res Clin Pract, 88, pp. 29-33. , COI: 1:CAS:528:DC%2BC3cXjtFyjsLc%3D, PID: 20129687; Zhou, J.Y., Chan, L., Zhou, S.W., (2014) Omentin: linking metabolic syndrome and cardiovascular disease, 12, pp. 136-143; Castan-Laurell, I., Dray, C., Knauf, C., Kunduzova, O., Valet, P., Apelin, a promising target for type 2 diabetes treatment (2012) Trends Endocrinol Metab, 23, pp. 234-241. , COI: 1:CAS:528:DC%2BC38XksFensLk%3D, PID: 22445464; Erdem, G., Dogru, T., Tasci, I., Sonmez, A., Tapan, S., Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus (2008) Exp Clin Endocrinol Diabetes, 116, pp. 289-292. , COI: 1:CAS:528:DC%2BD1cXovVSlu7g%3D, PID: 18484561; Machura, E., Szczepanska, M., Ziora, K., Ziora, D., Swietochowska, E., Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis (2013) Mediat Inflamm, 2013, pp. 119-127; Manica-Cattani, M.F., Bittencourt, L., Rocha, M.I., Algarve, T.D., Bodanese, L.C., Rech, R., Association between interleukin-1 beta polymorphism and obesity (2010) Mol Cell Endocrinol, 314, pp. 84-89. , COI: 1:CAS:528:DC%2BD1MXhtlWhtrvJ, PID: 19666082; Pitkin, S.L., Modulation of the apelin system in heart failure and atherosclerosis in human (2010) Br J Pharmacol, 160, pp. 1785-1795. , COI: 1:CAS:528:DC%2BC3cXhtlSju7rF, PID: 20649580; Mojtaba, E., Shahram, S., Heshmatolah, P., Alireza, Z., Pro-inflammatory cytokine interleukin-1 beta is associated with cardiovascular fitness in sedentary diabetic patients (2011) J Biodivers Environ Sci, 1, pp. 37-44; Zhao, G., Dharmadhikari, G., Maedler, K., Meyer-Hermann, M., Possible role of interleukin-1? in type 2 diabetes onset and implications for anti-inflammatory therapy strategies (2014) PLoS Comput Biol, 10, pp. 100-108; Trinder, P., Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen (1969) J Clin Pathol, 22, pp. 158-161. , COI: 1:CAS:528:DyaF1MXhtFaht7o%3D, PID: 5776547; Richmond, W., Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum (1973) Clin Chem, 19, pp. 1350-1356. , COI: 1:CAS:528:DyaE2cXht12ksrg%3D, PID: 4757363; Siedel, J., Hagele, E.O., Ziegenhorn, J., Wahlefeld, A.W., Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency (1983) Clin Chem, 29, pp. 1075-1080. , COI: 1:CAS:528:DyaL3sXksV2ktb0%3D, PID: 6851096; Burstein, M., Scholnick, H.R., Morfin, R., Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions (1970) J Lipid Res, 11, pp. 583-595. , COI: 1:CAS:528:DyaE3MXpsFw%3D, PID: 4100998; Hatch, F.T., Lees, R.S., Practical methods for plasma lipoprotein analysis (1968) Adv Lipid Res, 6, pp. 1-68. , COI: 1:CAS:528:DyaE3cXjvFGqsQ%3D%3D, PID: 4179999; Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Teacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and b cell function from fasting plasma glucose and insulin concentration in man (1985) Diabetologia, 28, pp. 412-419. , COI: 1:CAS:528:DyaL2MXlslKnu7k%3D, PID: 3899825; Chen, C.N., Li, Y.S.J., Yeh, Y.T., Lee, P.L., Synergistic roles of platelet-derived growth factor-BB and interleukin-1-beta in phenotypic modulation of human aortic smooth muscle cells (2006) Proc Nat Acad Sci, 103, pp. 2665-2670. , COI: 1:CAS:528:DC%2BD28XksF2rsbc%3D, PID: 16477012; Tan, B.K., Adya, R., Farhatullah, S., Lewandowski, K.C., O�Hare, P., Lehnert, H., Omentin?1, a novel adipokine, is decreased in overweight insulin resistant women with the polycystic ovary syndrome: ex vivo and in vivo regulation of omentin?1 by insulin and glucose (2008) Diabetes, 57, pp. 801-808. , COI: 1:CAS:528:DC%2BD1cXksVGktLY%3D, PID: 18174521; Principe, A., Melgar-Lesmes, P., Fern�ndez-Varo, G., Del Arbol, L.R., Ros, J., Bernardi, M., The hepatic apelin system: a new therapeutic target for liver disease (2008) Hepatology, 48, pp. 1193-1201. , COI: 1:CAS:528:DC%2BD1cXht1Khu7%2FP, PID: 18816630; Mirzaei, K., Hossein-Nezhad, A., Aslani, S., Emamgholipour, S., Karimi, M., Energy expenditure regulation via macrophage migration inhibitory factor (MIF) in obesity and in vitro anti-MIF effect of Alpinia officinarum Hance extraction (2011) Endocr Pract, 18, pp. 39-48; Van, R.E., Jankowski, C.M., Gozansky, W.S., Schwartz, R.S., Kohrt, W.M., Lower-body adiposity and metabolic protection in postmenopausal women (2005) J Clin Endocrinol Metab, 90, pp. 4573-4578; Casper, G., Coen, D.A., Vascular complications in diabetes mellitus: the role of endothelial dysfunction (2005) Clin Sci, 109, pp. 143-159; Caballero, A.E., Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease (2003) Obes Res, 11, pp. 1278-1289. , COI: 1:CAS:528:DC%2BD3sXpvFOksbY%3D, PID: 14627747; Arthur, S., Ulf, G., Dyslipidemia and risk of coronary heart disease: role of lifestyle approaches for its management (2009) Am J Life Style Med, 3, pp. 257-273; Defilippi, C.R., de Lemos, J.A., Christenson, R.H., Gottdiener, J.S., Kop, W.J., Zhan, M., Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults (2010) JAMA, 304, pp. 2494-2502. , COI: 1:CAS:528:DC%2BC3cXhsFKjsrnL, PID: 21078811; DeNardo, D., Latz, E., NLRP3 inflammasomes link inflammation and metabolic disease (2011) Trends Immunol, 32, pp. 373-379. , COI: 1:CAS:528:DC%2BC3MXpvFGgsrc%3D; Ohashi, K., Shibata, R., Murohara, T., Ouchi, N., Role of anti-inflammatory adipokines in obesity related diseases (2014) Trends Endocrinol Metab, 25, pp. 348-355. , COI: 1:CAS:528:DC%2BC2cXmsVCksbY%3D, PID: 24746980; Shibata, R., Ouchi, N., Kikuchi, R., Takahashi, R., Takeshita, K., Kataoka, Y., Circulating omentin is associated with coronary artery disease in men (2011) Atherosclerosis, 219, pp. 811-814. , COI: 1:CAS:528:DC%2BC3MXhsFCqsrrO, PID: 21925659; Zhong, X., Zhang, H.Y., Tan, H., Zhou, Y., Liu, F.L., Association of serum omentin-1 levels with coronary artery disease (2011) Acta Pharmacol Sin, 32, pp. 873-878. , COI: 1:CAS:528:DC%2BC3MXotlequrk%3D, PID: 21602837; Moreno-Navarrete, J.M., Catalan, V., Ortega, F., Gomez-Ambrosi, J., Ricart, W., Circulating omentin concentration increases after weight loss (2010) Nutr Metab, 7, pp. 27-38; Yang, R.Z., Lee, M.J., Hu, H., Pray, J., Wu, H.B., Hansen, B.C., Identification of omentin as a novel depot specific adipokine in human adipose tissue: possible role in modulating insulin action (2006) Am J Physiol Endocrinol Metab, 290, pp. 1253-1261; Soriguer, F., Garrido-Sanchez, L., Garcia-Serrano, S., Garcia-Almeida, J.M., Garcia-Arnes, J., Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus (2009) Obes Surg, 19, pp. 1574-1580. , PID: 19756893; Dray, C., Debard, C., Jager, J., Disse, E., Daviaud, D., Martin, P., Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans (2010) Am J Physiol Endocrinol Metab, 298, pp. 1161-1169; Higuchi, K., Masaki, T., Gotoh, K., Chiba, S., Katsuragi, I., Tanaka, K., Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice (2007) Endocrinology, 148, pp. 2690-2697. , COI: 1:CAS:528:DC%2BD2sXmt1ajt7s%3D, PID: 17347313; Beltowski, J., Apelin and visfatin: unique �beneficial� adipokines up-regulated in obesity (2006) Med Sci Monit, 12, pp. 112-119; Attane, C., Daviaud, D., Dray, C., Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo (2011) J Mol Endocrinol, 46, pp. 21-28. , COI: 1:CAS:528:DC%2BC3MXjt1ahsrk%3D, PID: 21062936; Garcia-Diaz, D., Campion, J., Milagro, F.I., Martinez, J.A., Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers (2007) Mol Cell Biochem, 305, pp. 87-94. , COI: 1:CAS:528:DC%2BD2sXhtFSksLvE, PID: 17594060 |
|